| Oct 23 |
TuHURA Biosciences (Nasdaq: HURA) Announces Webcast Replay of Panel Presentation at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
|
| Oct 22 |
TuHURA Biosciences (NASDAQ:HURA) to Present at the Virtual Investor "New to the Street" Event
|
| Oct 17 |
TuHURA Biosciences Completes Merger Transaction with Kintara Therapeutics
|
| Oct 16 |
Kintara Therapeutics Announces Correction to Prior Announcement Regarding 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences to Close on October 18, 2024
|
| Oct 16 |
Kintara Therapeutics Announces 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences
|
| Oct 15 |
Kintara Therapeutics Announces Correction to Prior Announcement Regarding CVR Issuance in Connection with the Proposed Merger with TuHURA Biosciences Expected to Close on October 18, 2024
|
| Oct 14 |
Kintara stock climbs 10% on TuHURA merger update
|
| Oct 14 |
Kintara Therapeutics Announces Record Date for CVR Issuance in Connection with the Proposed Merger with TuHURA Biosciences Expected to Close on October 18, 2024
|
| Oct 9 |
Kintara Therapeutics Reveals Improved Financials, Merger Plans
|
| Oct 8 |
Kintara Therapeutics Announces Fiscal 2024 Financial Results and Provides Corporate Update
|
